Press Releases

25-11-2002

500th Patient of Prostate Cancer to be Cured with BEBIG Seeds in the Institut Curie

22-11-2002

IPL Announces First Ever Sealed-Source. Multimodal Marker For Fusion Imaging in Nuclear Medicine

12-11-2002 (Ad hoc press release)

Eckert & Ziegler: Strong Profit Growth in the Third Quarter

10-10-2002

Eckert & Ziegler: NEMOD and IDM Announce the Signature of a Joint Research Agreement

13-08-2002 (Ad hoc press release)

Eckert & Ziegler AG: Uphill Struggle against the Dollar Exchange Rate. Successes with Immunological Products.

28-05-2002

Eckert & Ziegler: Double-Digit Growth in First Quarter

21-05-2002 (Ad hoc press release)

Eckert & Ziegler granted FDA clearance for prostate seeds

15-05-2002 (Ad hoc press release)

Eckert & Ziegler to Market Prostate Cancer Products in the U.S. Shareholder Meeting Approves Dividend.

06-05-2002 (Ad hoc press release)

Successful First Quarter for Eckert & Ziegler

23-04-2002 (Ad hoc press release)

Eckert & Ziegler: Stock Buy Back Programm Approved

27-03-2002 (Ad hoc press release)

Eckert & Ziegler: Profit for the year 2001 rises by about 160%. Operational cash flow increases by 174%.

24-01-2002 (Ad hoc press release)

Eckert & Ziegler: annual turnover for 2001 up by nearly 40%. Additions to the Managing Board at NEMOD Immuntherapie AG